Omnicell Return on Tangible Equity 2010-2024 | OMCL

Current and historical return on tangible equity values for Omnicell (OMCL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Omnicell Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.02B $0.30B -6.43%
2024-06-30 $-0.02B $0.27B -8.06%
2024-03-31 $-0.02B $0.25B -9.08%
2023-12-31 $-0.02B $0.24B -9.41%
2023-09-30 $-0.03B $0.23B -17.87%
2023-06-30 $-0.02B $0.20B -13.53%
2023-03-31 $-0.02B $0.17B -11.79%
2022-12-31 $0.01B $0.15B 5.12%
2022-09-30 $0.05B $0.15B 43.05%
2022-06-30 $0.06B $0.10B 42.18%
2022-03-31 $0.07B $0.07B 32.68%
2021-12-31 $0.08B $0.13B 26.69%
2021-09-30 $0.08B $0.28B 23.87%
2021-06-30 $0.06B $0.40B 15.55%
2021-03-31 $0.04B $0.35B 8.99%
2020-12-31 $0.03B $0.30B 7.85%
2020-09-30 $0.04B $0.47B 8.86%
2020-06-30 $0.05B $0.44B 12.33%
2020-03-31 $0.07B $0.42B 18.97%
2019-12-31 $0.06B $0.38B 18.97%
2019-09-30 $0.05B $0.34B 19.60%
2019-06-30 $0.05B $0.30B 21.55%
2019-03-31 $0.04B $0.26B 22.81%
2018-12-31 $0.04B $0.20B 31.08%
2018-09-30 $0.06B $0.13B 62.86%
2018-06-30 $0.05B $0.10B 108.89%
2018-03-31 $0.04B $0.07B 880.00%
2017-12-31 $0.03B $0.05B -98.41%
2017-09-30 $0.01B $-0.04B -13.85%
2017-06-30 $0.00B $-0.06B -4.08%
2017-03-31 $-0.00B $-0.07B 0.00%
2016-12-31 $0.01B $-0.09B -11.14%
2016-09-30 $0.01B $-0.07B -33.33%
2016-06-30 $0.02B $-0.09B 52.63%
2016-03-31 $0.03B $-0.11B 27.55%
2015-12-31 $0.03B $0.17B 18.42%
2015-09-30 $0.03B $0.15B 18.47%
2015-06-30 $0.03B $0.16B 17.37%
2015-03-31 $0.03B $0.20B 16.09%
2014-12-31 $0.03B $0.19B 16.74%
2014-09-30 $0.03B $0.17B 16.28%
2014-06-30 $0.03B $0.19B 17.06%
2014-03-31 $0.03B $0.17B 17.09%
2013-12-31 $0.02B $0.16B 16.41%
2013-09-30 $0.02B $0.16B 17.04%
2013-06-30 $0.02B $0.14B 18.57%
2013-03-31 $0.02B $0.13B 16.11%
2012-12-31 $0.02B $0.11B 11.55%
2012-09-30 $0.01B $0.10B 8.08%
2012-06-30 $0.01B $0.09B 4.76%
2012-03-31 $0.01B $0.26B 4.84%
2011-12-31 $0.01B $0.25B 4.55%
2011-09-30 $0.01B $0.25B 3.37%
2011-06-30 $0.01B $0.24B 2.58%
2011-03-31 $0.01B $0.23B 2.17%
2010-12-31 $0.01B $0.23B 2.20%
2010-09-30 $0.01B $0.23B 2.24%
2010-06-30 $0.01B $0.23B 2.28%
2010-03-31 $0.00B $0.22B 1.86%
2009-12-31 $0.00B $0.21B 0.48%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.964B $1.147B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00